MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation

European Radiology

Volumn 23, Issue 3, 2013, Pages 827-835

  Van De Maat, Gerrit H ^a   Seevinck, Peter R ^a   Elschot, Mattijs ^b   Smits, Maarten L J ^b   De Leeuw, Hendrik ^a   Van Het Schip, Alfred D ^b   Vente, Maarten A D ^b   Zonnenberg, Bernard A ^b   De Jong, Hugo W A M ^b   Lam, Marnix G E H ^b   Viergever, Max A ^a   Van Den Bosch, Maurice A A J ^b   Nijsen, Johannes F W ^b   Bakker, Chris J G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Biodistribution; Dosimetry; Holmium; MRI; Radioembolisation

Indexed keywords

MACROSALB TC 99M; MICROSPHERE; POLYLACTIC ACID HO 166; RADIOPHARMACEUTICAL AGENT; TECHNESCAN LYOMAA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CT SPECT SCANNER; DOSIMETRY; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; FEASIBILITY STUDY; FEMALE; GAMMA CAMERA; HUMAN; LIVER; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOEMBOLIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER;

EID: 84878590833     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2648-2     Document Type: Article

References (34)

1. Salem R, Thurston KG (2006) Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. J Vasc Interv Radiol 17:1571-1594
2. Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412-425
3. Vente MAD, Hobbelink MGG, van het Schip AD, Zonnenberg BA, Nijsen JFW (2007) Radionuclide liver cancer therapies: from concept to current clinical status. Anticancer Agents Med Chem 7:441-459
4. Gulec SA, Fong Y (2007) Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 142:675-682
5. Vente MAD, Wondergem M, van der Tweel I et al (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951-959
6. Bult W, Vente MAD, Zonnenberg BA, Nijsen JFW (2009) Microsphere radioembolzation of liver malignancies: current developments. Q J Nucl Med Mol Imaging 53:325-335
7. Fabbri C, Sarti G, Cremonesi M et al (2009) Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry. Cancer Biother Radiopharm 24:145-154
8. Minarik D, Sjögreen-Gleisner K, Ljungberg M (2008) Evaluation of quantitative 90Y SPECT based on experimental phantom studies. Phys Med Biol 53:5689-5703
9. Minarik D, Sjögreen-Gleisner K, Linden O et al (2010) 90Y Bremsstrahlung imaging for abosrbed-dose assessment in high-dose radioimmunotherapy. J Nucl Med 51:1974-1978
10. Elschot M, Nijsen JFW, Dam AJ, de Jong HWAM (2011) Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization. PLoS One 6:e26174
11. Lhommel R, van Elmbt L, Goffette P et al (2010) Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-spheres. Eur J Nucl Med Mol Imaging 37:1654-1662
12. Gates VL, Esmail AAH, Marshall K, Spies S, Salem R (2011) Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med 52:72-76
13. Gupta T, Virmani S, Neidt TM et al (2008) MR Tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study. Radiol 249:845-854
14. Nijsen JFW, Zonnenberg BA, Woittiez JRW et al (1999) Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. Eur J Nucl Med 26:699-704
15. Nijsen JFW, van Steenbergen MJ, Kooijman H et al (2001) Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonate. Biomaterials 22:3073-3081
16. Nijsen JFW, Seppenwoolde JH, Havenith T, Bos C, Bakker CJG, van het Schip AD (2004) Liver tumors: MR imaging of radioactive holmium microspheres - phantom and rabbit study. Radiol 231:491-499
17. Seppenwoolde JH, Nijsen JFW, Bartels LW, Zielhuis SW, van het Schip AD, Bakker CJG (2005) Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn Reson Med 53:76-84
18. Vente MAD, Nijsen JFW, de Wit TC et al (2008) Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs. Eur J Nucl Med Mol Imaging 7:1259-1271
19. Seevinck PR, Seppenwoolde JH, de Wit TC et al (2007) Factors affecting the sensitivity and detection limits of MRI, CT, and SPECT for multimodal diagnostic and therapeutic agents. Anticancer Agents Med Chem 7:317-334
20. Seevinck PR, van de Maat GH, de Wit TC, Vente MAD, Nijsen JFW, Bakker CJG (2012) Magnetic resonance imaging-based radiation-absorbed dose estimation of 166-Ho microspheres in liver radioembolization. Int J Rad Oncol Biol Phys 83:e437-e444
21. Vente MA, Nijsen JF, de Roos R et al (2009) Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study. Biomed Microdevices 11:763-772
22. Smits MLJ, Nijsen JFW, van den Bosch et al (2010) Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial. J Exp Clin Cancer Res 29:70
23. Coldwell D, Sangro B, Wasan H, Salem R, Kennedy A (2011) General selection criteria of patients for radioembolization of liver tumors: an international working group report. Am J Clin Oncol 34:337-341
24. Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using ytrrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13-23
25. Leung WT, Lau WY, Ho SKW et al (1994) Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99 m macroaggregated albumin. J Nucl Med 35:70-73
26. de Wit T, Xiao J, Nijsen JF et al (2006) Hybrid scatter correction applied to quantitative holmium-166 SPECT. Phys Med Biol 51:4773-4787
27. Brown MA, Carden JA, Coleman RE, McKinney R Jr, Spicer LD (1987) Magnetic field effects on surgical ligation clips. Magn Reson Imag 5:443-453
28. Czervionke LF, Daniels DL, Wehrli FW et al (1988) Magnetic susceptibility artifacts in gradient-recalled echo MR imaging. Am J Neuroradiol 9:1149-1155
29. Port JD, Pomper MG (2000) Quantification and minimization of magnetic susceptibility artifacts on GRE images. J Comput Assist Tomogr 24:958-964
30. Bolch WE, Bouchet LG, Robertson JS et al (1999) MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions - radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med 40:11S-36S
31. International Commission on Radiation Units and Measurements (1989) Tissue Substitutes in Radiation Dosimetry and Measurement. 44th edn. Bethesda, MD
32. Kamel IR, Bluemke DA (2002) Imaging evaluation of hepatocellular carcinoma. J Vasc Interv Radiol 13:S173-S183
33. Rummeny E, Weissleder R, Stark DD et al (1989) Primary liver tumours: diagnosis by MR imaging. Am J Roentgenol 152:63-72
34. Seppenwoolde JH, Bartels LW, van der Weide R, Nijsen JFW, van het Schip AD, Bakker CJG (2006) Fully MR-guided hepatic artery catheterization for selective drug delivery: a feasibility study in pigs. J Magn Reson Imaging 23:123-129